EsoCap and Upadia sign licensing agreement to develop therapeutics to treat Barrett's esophagus Jan. 10, 2022
uPA-uPAR blockade protects intestinal epithelial barrier from inflammation-induced damage Jan. 4, 2022
Extension of Series A financing at Ambys supports progression of AMI-918 for liver disease Dec. 21, 2021
RSS